Requirement of AMPK activation for neuronal metabolic-enhancing effects of antidepressant paroxetine.

Jeong, Jihyeon; Park, Minsun; Yoon, Jeong Seon; Kim, Hyunjeong; Lee, Su Kyoung; Lee, Eun; Namkoong, Kee; Kim, Eosu

Jeong, Jihyeon; Park, Minsun; Yoon, Jeong Seon; Kim, Hyunjeong; Lee, Su Kyoung; Lee, Eun; Namkoong, Kee; Kim, Eosu.

Affiliation

Jeong J; aDepartment of Psychiatry, Institute of Behavioral Science in Medicine bBrain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

Neuroreport ; 26(7): 424-8, 2015 May 06.

Article in En | MEDLINE | ID: mdl-25839176

Subject(s)

AMP-Activated Protein Kinases/metabolism; Antidepressive Agents/pharmacology; Neurons/drug effects; Neurons/metabolism; Paroxetine/pharmacology; Selective Serotonin Reuptake Inhibitors/pharmacology; AMP-Activated Protein Kinases/antagonists & inhibitors; Adenosine Triphosphate/metabolism; Cell Line, Tumor; Cell Survival/drug effects; Dose-Response Relationship, Drug; Energy Metabolism/drug effects; Glucose/metabolism; Humans; Mitochondria/drug effects; Mitochondria/metabolism; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Transcription Factors/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Selective Serotonin Reuptake Inhibitors / Paroxetine / AMP-Activated Protein Kinases / Antidepressive Agents / Neurons Limits: Humans Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google